Seeing Is Believing
Currently out of the existing stock ratings of Gena Wang, 209 are a BUY (67.2%), 70 are a HOLD (22.51%), 32 are a SELL (10.29%).
Analyst Gena Wang, currently employed at BARCLAYS, carries an average stock price target met ratio of 62.72% that have a potential upside of 26.7% achieved within 173 days.
Gena Wang’s has documented 601 price targets and ratings displayed on 43 stocks. The coverage is on Healthcare, Energy, Technology sectors.
Most recent stock forecast was given on BLUE, Bluebird bio at 31-Dec-2024.
Analyst best performing recommendations are on SMCI (SUPER MICRO COMPUTER).
The best stock recommendation documented was for BLUE (BLUEBIRD BIO) at 11/15/2024. The price target of $2 was fulfilled within 28 days with a profit of $1.68 (525%) receiving and performance score of 187.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$300
$21.24 (7.62%)
$300
9 days ago
(21-Jan-2025)
20/22 (90.91%)
$53.73 (21.82%)
220
Buy
$400
$121.24 (43.49%)
$400
17 days ago
(13-Jan-2025)
1/22 (4.55%)
$151.69 (61.09%)
664
Buy
$320
$41.24 (14.79%)
$320
17 days ago
(13-Jan-2025)
12/16 (75%)
$71.69 (28.87%)
215
Buy
$296
$17.24 (6.18%)
$217
2 months 12 days ago
(18-Nov-2024)
48/49 (97.96%)
$61.91 (26.45%)
447
Buy
$329
$50.24 (18.02%)
$295
2 months 29 days ago
(01-Nov-2024)
17/18 (94.44%)
$55.09 (20.11%)
247
Which stock is Gena Wang is most bullish on?
Which stock is Gena Wang is most reserved on?
What Year was the first public recommendation made by Gena Wang?